Survival outcomes of rare cutaneous malignancies within an insured cohort of patients, 1988-2018.
J Am Acad Dermatol
; 90(2): 328-338, 2024 Feb.
Article
em En
| MEDLINE
| ID: mdl-37714218
ABSTRACT
BACKGROUND:
There are limited survival data on cutaneous angiosarcoma (CAS), dermatofibrosarcoma protuberans (DFSP), Merkel cell carcinoma (MCC), and sebaceous carcinoma (SC).OBJECTIVE:
To analyze survival trends in CAS, DFSP, MCC, and SC among a racially diverse, insured cohort of patients.METHODS:
Using data from the Kaiser Permanente Southern California Cancer Registry, we identified adults diagnosed with CAS, DFSP, MCC, or SC between January 1, 1988 and December 31 2018, followed through December 31, 2021.RESULTS:
Our cohort consisted of 83 diagnoses of CAS, 490 diagnoses of DFSP, 411 diagnoses of MCC, and 249 diagnoses of SC. Our analysis revealed no significant differences in overall or disease-specific 1000 person-years mortality rates among our populations of non-Hispanic Whites, Hispanics, African American/Blacks, and Asian American/Pacific Islanders diagnosed with CAS, DFSP, MCC, or SC. On multivariate analysis, controlling for patient and tumor characteristics, there was similarly no increased risk of overall mortality for minorities diagnosed with CAS, DFSP, MCC, or SC.LIMITATIONS:
Retrospective nature of the analysis and small sample size.CONCLUSION:
Contrary to existing literature, our results show a notable lack of racially driven survival disparities among insured individuals with CAS, DFSP, MCC, and SC, emphasizing the importance of health care coverage.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias das Glândulas Sebáceas
/
Neoplasias Cutâneas
/
Carcinoma de Célula de Merkel
/
Dermatofibrossarcoma
/
Adenocarcinoma Sebáceo
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Aspecto:
Equity_inequality
Limite:
Adult
/
Humans
Idioma:
En
Revista:
J Am Acad Dermatol
Ano de publicação:
2024
Tipo de documento:
Article